Peter van der Ark

3PUBLICATIONS
2CO-AUTHORS
Inter-organisational, extra-organisational and global information systemsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 16, 2019
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.

Sander Brooks, Gabriël E Jacobs, Peter de Boer

|Sep 06, 2018
Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects.

Peter D van der Ark, Georg Golor, Luc van Nueten

|Jun 01, 2018
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity.

Peter De Boer, Wayne C Drevets, Hany Rofael

Pageof 1

Frequent Collaborators

3 joint publications

Peter de Boer

1 joint publications

Sander Brooks